DE2544881A1 - Tablette - Google Patents

Tablette

Info

Publication number
DE2544881A1
DE2544881A1 DE19752544881 DE2544881A DE2544881A1 DE 2544881 A1 DE2544881 A1 DE 2544881A1 DE 19752544881 DE19752544881 DE 19752544881 DE 2544881 A DE2544881 A DE 2544881A DE 2544881 A1 DE2544881 A1 DE 2544881A1
Authority
DE
Germany
Prior art keywords
tablet
tablets
maltose
tablet according
weight
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
DE19752544881
Other languages
German (de)
English (en)
Inventor
Eiichiro Akito
Minoru Nakata
Hiroshi Otaki
Koichi Yoshida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hayashibara Seibutsu Kagaku Kenkyujo KK
Nippon Kayaku Co Ltd
Original Assignee
Nippon Kayaku Co Ltd
Hayashibara Biochemical Laboratories Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Kayaku Co Ltd, Hayashibara Biochemical Laboratories Co Ltd filed Critical Nippon Kayaku Co Ltd
Publication of DE2544881A1 publication Critical patent/DE2544881A1/de
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
DE19752544881 1974-10-08 1975-10-07 Tablette Pending DE2544881A1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11521374A JPS5154918A (en) 1974-10-08 1974-10-08 Jozaino seizoho

Publications (1)

Publication Number Publication Date
DE2544881A1 true DE2544881A1 (de) 1976-04-22

Family

ID=14657155

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19752544881 Pending DE2544881A1 (de) 1974-10-08 1975-10-07 Tablette

Country Status (4)

Country Link
JP (1) JPS5154918A (ja)
DE (1) DE2544881A1 (ja)
FR (1) FR2287215A1 (ja)
GB (1) GB1480175A (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114431477A (zh) * 2022-03-01 2022-05-06 广州市沐家健康产业有限公司 一种益生菌压片制剂及其制备方法和应用
CN115956635A (zh) * 2022-12-26 2023-04-14 广西商大科技股份有限公司 一种断奶仔猪片状教槽料及其制备方法

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52133823A (en) * 1976-05-04 1977-11-09 Kurogane Zoukeiki Kk Molding machine
DE3221425A1 (de) * 1982-06-07 1983-12-08 Boehringer Ingelheim KG, 6507 Ingelheim Hydrolyseempfindlichen wirkstoff enthaltende, lagerstabile tablette
DE3891219T1 (de) * 1988-01-22 1990-02-01 Kh Nii Endokrinologii I Chimii P-chlorphenoxysobuttersaeureundezylester und arzneimittel auf dessen grundlage zur behandlung der hyperlipidaemie
US5629016A (en) * 1991-01-30 1997-05-13 Glaxo Wellcome Inc. Water-dispersible tablets
SK282071B6 (sk) * 1991-01-30 2001-10-08 The Wellcome Foundation Limited Tableta dispergovateľná vo vode a spôsob jej prípravy
GB9215908D0 (en) * 1992-07-27 1992-09-09 Wellcome Found Water dispersible tablets
US5698226A (en) * 1993-07-13 1997-12-16 Glaxo Wellcome Inc. Water-dispersible tablets
TW550082B (en) * 1998-01-14 2003-09-01 Daiichi Seiyaku Co Disintegrant
EP1161941A4 (en) * 1999-03-15 2002-08-28 Kaken Pharma Co Ltd FAST DELITING TABLETS AND MANUFACTURING METHOD
AT409083B (de) * 1999-04-01 2002-05-27 Sanochemia Pharmazeutika Ag Pharmazeutische, tolperison enthaltende zubereitung zur oralen verabreichung
HUP0700485A3 (en) * 2007-07-23 2010-01-28 Richter Gedeon Nyrt Pharmaceutical composition with controlled release containing tolperisone

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3627583A (en) * 1969-04-29 1971-12-14 Sucrest Corp Direct compression vehicles

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN114431477A (zh) * 2022-03-01 2022-05-06 广州市沐家健康产业有限公司 一种益生菌压片制剂及其制备方法和应用
CN115956635A (zh) * 2022-12-26 2023-04-14 广西商大科技股份有限公司 一种断奶仔猪片状教槽料及其制备方法

Also Published As

Publication number Publication date
JPS5436644B2 (ja) 1979-11-10
FR2287215A1 (fr) 1976-05-07
JPS5154918A (en) 1976-05-14
GB1480175A (en) 1977-07-20
FR2287215B1 (ja) 1980-04-25

Similar Documents

Publication Publication Date Title
DE69100804T2 (de) Enzymatisch entzweigte Stärken als Tablettenhilfsmittel.
DE69400356T2 (de) Quervernetzte amylose als bindemittel/sprengmittel fuer tabletten
DE69915718T2 (de) Fliessfähige, direktverpressbare Stärke als Bindemittel, Sprengmittel und Füllstoff für Presstabletten und Hartgelatinkapseln
AT393081B (de) Verfahren zur herstellung von cefuroximaxetilfilmtabletten
DE2544881A1 (de) Tablette
DE69735644T2 (de) Nateglinide zubereitung in tablettenform
DE69722247T2 (de) Pharmazeutische tablette mit verzögerter freisetzung, enthaltend eine matrix aus quervernetzter amylose und hydroxypropyl methylzellulose
DE69803159T2 (de) Herstellung von vernetzter amylose als hilfstoff zur kontrollierten freisetzung von wirkstoffen
DE3048028A1 (de) Molekulares koordinationskomplexprodukt
DE2808514A1 (de) Nitrofurantoin enthaltende tablette
DE1467781A1 (de) Verfahren zur Herstellung von Dragees mit verlaengerter Wirkstofffreigabe
DE2128461A1 (de) Pharmazeutisches Präparat
DE69302580T2 (de) Vernetztes polyhydroxyl-material zur enzymatisch gesteuerten arzneistofffreisetzung
EP0468247A1 (de) Verfahren zur Herstellung mechanisch stabiler, gut zerfallender Komprimate aus kleindimensionierten Extrusionspellets mit hohem Etofibratgehalt
DE3872862T2 (de) Zusammensetzung zur herstellung eines haertbaren calciumphosphatartigen materials und verfahren zur herstellung eines derartigen materials.
CH656535A5 (en) Process for the production of stable pharmaceutical tablets which disintegrate rapidly in water
EP0186090B1 (de) Verfahren zur Herstellung von Ascorbinsäure-Granulat
DE3150557C2 (ja)
DE69104220T2 (de) Verfahren zur Herstellung von direktkomprimierten, Cephalosporansäure Derivate enthaltendenTabletten.
DE2462081A1 (de) Pilocarpinpamoat sowie dieses enthaltende arzneimittel
DE2830895A1 (de) Aluminiumoxidsubstrate und verfahren zu ihrer herstellung
DE69206031T2 (de) Tablettierhilfsstoff.
DE3142853C2 (ja)
EP0537139B1 (de) Verfahren zur herstellung geformter, verpresster dosiseinheiten mit retardierter freisetzung und entsprechende dosiseinheit
WO1999032090A1 (de) Verfahren zum herstellen von extrakt enthaltenden pharmazeutischen formulierungen

Legal Events

Date Code Title Description
OHJ Non-payment of the annual fee